Implantable cardiac arrhythmia devices - Part II: Implantable cardioverter defibrillators and implantable loop recorders

Clinical Cardiology

Volumn 29, Issue 6, 2006, Pages 237-242

  Kusumoto, Fred ^a   Goldschlager, Nora ^b,c  

^a MAYO CLINIC   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac resynchronization; Defibrillators; Implantable devices; Loop recorder; Pacemakers; Syncope

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO;

BRUGADA SYNDROME; CARDIOVERSION; CLINICAL TRIAL; DEFIBRILLATOR; HEART ARREST; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE LOOP RECORDER; LONG QT SYNDROME; MORTALITY; RECORDER; RELIABILITY; REVIEW; RISK FACTOR; SAFETY; SYNCOPE;

ARRHYTHMIA; CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; SYNCOPE;

EID: 33744980953     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960290603     Document Type: Review

References (32)

1. AVID Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-1583
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B: Canadian Implantable Defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator. Circulation 2000;101;1297-1301
3. Wyse GD, Friedman PL, Brodsky MA, Beckman KJ, Carlson MD, Curtis AB, Hallstrom AP, Raitt MA, Wilkoff BL, Greene HL, for the AVID Investigators: Life-threatening ventricular arrhythmias due to transient or correctable causes: High risk for death in follow-up. J Am Coll Cardiol 2001; 38:1718-1724
4. Ehlert FA, Cannom DS, Renfroe EG: Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry. Am Heart J 2001;142:816-822
5. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators: Electrophysiology testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000;342:1937-1945
6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940
7. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:182-190
8. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daibert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-893
9. Bardy G, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Faulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237
10. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, for the DINAMIT Investigators: Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488
11. Malm S, Frigstad S, Sagberg E, Larssson H, Skjaerpe T: Accuracy and reproducibile measurement of left ventricular volume and ejection fraction by contrast echocardiography: A comparison with magnetic resonance imaging. J Am Coll Cardiol 2004;44:1030-1035
12. Wilber D, Zareba W, Hall W, Brown MW, Lin AC, Andrews ML, Burke M, Moss AJ: Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109:1082-1084
13. Solomon SD, Zelenkofske S, McMurray JVJ, Finn PV, Velazquez E, Ertl G, Haranyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, for the Valsartant in Acute Myocardial Infarction Trial (VALIANT) Investigators: Sudden death in patients with myocardial infarcion and left ventricular dysfunction, heart failure, or both. N Engl J Med 352:2581-2588
14. Sanders GD, Hlatky MA, Every NR: Potential cost-effectiveness of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Ann Intern Med 2001;135:870-883
15. Hlatky MA: Evidence-based use of cardiac procedures and devices. N Engl J Med 2004;350:2126-2128
16. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F, for the AMIOVIRT Investigators: Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003;41:1707-1712
17. Bansch D, Antz M, Boczor S, Volkmer Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-1458
18. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350: 2151-2158
19. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT: Hypertrophic cardiomyopathy in a large community-based population. Clinical outcome and identification of risk factors for sudden cardiac death and deterioration. J Am Coll Cardiol 2003;41:987-993
20. Maron BJ, Shen W-K, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P: Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-373
21. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M: Implantable cardioverter defibrillator in high-risk long QT patients. J Cardiovasc Electrophysiol 2003;14:337-341
22. Brugada P, Brugada R, Brugada J: The Brugada syndrome. Curr Cardiol Rev 2000;2:507-514
23. Nademanee K, Veerakul G, Mower M, Likittanasombat K, Krittayapong R, Bhuripanyo K, Sitthisook S, Chaothawee L, Lai MY, Anzen SP: Defibrillator vs. Beta Blockers for unexpected death in Thailand (DEBUT): A randomized clinical trial. Circulation 2003;107:221-226
24. Silka MJ, Hardy BG, Menashe VD, Morris CD: A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998;32:245-251
25. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J: Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 2002;40:1675-1680
26. Glikson M, Luria D, Friedman PA, Trusty JM, Benderly M, Hammill SC, Stanton MS: Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? J Cardiovasc Electrophysiol 2000;11:127-135
27. US Food and Drug Administration Website: Medtronic issues notification regarding certain implantable defibrillator models. Available at http://www.fda.gov/oc/po/firmrecalls/medtronic20_05.html. Accessed September 16, 2005
28. US Food and Drug Administration Website: FDA statement on Guidant Corporations worldwide physician communications. Available at http://www.fda.gov/opacon/Enforce.html. Accessed September 16, 2005
29. Maisel WH: Safety issues involving medical devices. J Am Med Assoc 2005;294:955-958
30. Krahn AD, Klein GJ, Yee R, Skanes AC: Randomized Assessment of Syncope Trial. Circulation 2001:46-51
31. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S, Mont L, Botto G, Giada F, Cornacchia D, for the International Study on Syncope of Uncertain Etiology (ISSUE) Investigators: Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001;104:1261-1267
32. Menozzi C, Brignole M, Garcia-Civera R, Moya A, Botto G, Tercedor L, Migliorini R, Navarro X, for the International Study on Syncope of Uncertain Etiology (ISSUE) Investigators: Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 2002;105:2741-2745